Anti-resorptive and anabolic bone agents

被引：3
作者：
Hartman, GD [1 ]
Meissner, RS [1 ]
机构：
[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 39 | 2004年 / 39卷
关键词：
D O I：
10.1016/S0065-7743(04)39006-8
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：67 / 78
页数：12
相关论文
共 68 条
[1]   Oestrogen and selective oestrogen receptor modulators (SERMs): current roles in the prevention and treatment of osteoporosis [J].
Albertazzi, P ;
Purdie, DW .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2001, 15 (03) :451-468
[2]   Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors [J].
Altmann, E ;
Renaud, J ;
Green, J ;
Farley, D ;
Cutting, B ;
Jahnke, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) :2352-2354
[3]   TREATMENT OF OVARIECTOMIZED RATS WITH THE COMPLEX OF RHIGF-I/IGFBP-3 INCREASES CORTICAL AND CANCELLOUS BONE MASS AND IMPROVES STRUCTURE IN THE FEMORAL-NECK [J].
BAGI, CM ;
DELEON, E ;
BROMMAGE, R ;
ROSEN, D ;
SOMMER, A .
CALCIFIED TISSUE INTERNATIONAL, 1995, 57 (01) :40-46
[4]   The effect of a single dose of osteoprotegerin in postmenopausal women [J].
Bekker, PJ ;
Holloway, D ;
Nakanishi, A ;
Arrighi, M ;
Leese, PT ;
Dunstan, CR .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :348-360
[5]   Novel therapies for osteoporosis [J].
Biskobing, DM .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) :611-621
[6]   The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis [J].
Black, DM ;
Greenspan, SL ;
Ensrud, KE ;
Palermo, L ;
McGowan, JA ;
Lang, TF ;
Garnero, P ;
Bouxsein, ML ;
Bilezikian, JP ;
Rosen, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1207-1215
[7]  
BOONEN S, 2002, J CLIN ENDOCRINOL, V87, P1539
[8]   Effects of hormone therapy on bone mineral density - Results from the postmenopausal estrogen/progestin interventions (PEPI) trial [J].
Bush, TL ;
Wells, HB ;
James, MK ;
BarrettConnor, E ;
Marcus, R ;
Greendale, G ;
Hunsberger, S ;
McGowan, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (17) :1389-1396
[9]   Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial [J].
Cauley, JA ;
Robbins, J ;
Chen, Z ;
Cummings, SR ;
Jackson, RD ;
LaCroix, AZ ;
LeBoff, M ;
Lewis, CE ;
McGowan, J ;
Neuner, J ;
Pettinger, M ;
Stefanick, ML ;
Wactawski-Wende, J ;
Watts, NB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1729-1738
[10]   Effects of hormone replacement therapy on clinical fractures and height loss: The heart and estrogen/progestin replacement study (HERS) [J].
Cauley, JA ;
Black, DM ;
Barrett-Connor, E ;
Harris, F ;
Shields, K ;
Applegate, W ;
Cummings, SR .
AMERICAN JOURNAL OF MEDICINE, 2001, 110 (06) :442-450
1234567